KCNMA1 and cancer: Such a variety in the impact of BK agonists and blockers does not necessarily question the results reported in the literature nor preclude the importance of these molecules in specific cases, but it can raise an alarm flag regarding the use of presumably specific BK channel modulators as anti-cancer agents.